Mullen E E, Deutsch M, Bloomer W D
Department of Radiation Oncology, University of Pittsburgh, PA, USA.
Radiother Oncol. 1997 Jan;42(1):25-9. doi: 10.1016/s0167-8140(96)01864-6.
In-breast tumor recurrence (IBTR) following lumpectomy and breast irradiation is usually managed by mastectomy. For women who refused mastectomy at the time of an IBTR, a repeat course of radiotherapy following repeat lumpectomy was offered.
Sixteen women with an IBTR following lumpectomy, axillary node dissection and breast irradiation were treated with repeat lumpectomy and radiotherapy to the operative area. Fifteen patients received 5000 cGy/25 fractions. One patient discontinued radiotherapy for non-medical reasons after having received only 3200 cGy/16 fractions. The interval from completion of the initial course of radiotherapy to documentation of IBTR varied from 10-130 months (median 31 months).
Four patients (20%) have had further local failure. Ten of sixteen patients (62.5%) are alive and free or disease at 42-119 months from completion of the repeat course of radiotherapy. Of these latter patients, one had another in-breast tumor recurrence treated by excision alone and another had an in-breast tumor recurrence in the contra lateral breast post-lumpectomy and irradiation. Four patients died with distant metastasis, one is currently alive with contralateral breast cancer and distant metastasis, and one is alive with an extensive recurrence in the re-irradiated breast. Two of the patients with distant metastasis had abnormal bone scans at the time they received the repeat course of radiotherapy. There have been no severe late sequelae from the repeat course of radiotherapy.
For selected patients, a repeat course of radiotherapy for an IBTR following lumpectomy and radiotherapy is well tolerated and may provide long-term local control.
保乳手术及乳房放疗后乳腺内肿瘤复发(IBTR)通常采用乳房切除术治疗。对于在IBTR时拒绝乳房切除术的女性,在再次行保乳手术后给予再次放疗。
16例保乳手术、腋窝淋巴结清扫及乳房放疗后出现IBTR的女性接受了再次保乳手术及手术区域放疗。15例患者接受了5000 cGy/25次分割放疗。1例患者仅接受了3200 cGy/16次分割放疗后因非医学原因中断放疗。从初次放疗结束至记录到IBTR的时间间隔为10 - 130个月(中位时间31个月)。
4例患者(20%)出现了进一步的局部复发。16例患者中有10例(62.5%)在再次放疗结束后42 - 119个月存活且无疾病。在这些患者中,1例出现了另一次乳腺内肿瘤复发,仅行切除术治疗;另1例在保乳手术及放疗后对侧乳腺出现了乳腺内肿瘤复发。4例患者死于远处转移,1例目前存活,患有对侧乳腺癌及远处转移,1例存活,再次放疗的乳腺出现广泛复发。2例发生远处转移的患者在接受再次放疗时骨扫描异常。再次放疗未出现严重的晚期后遗症。
对于部分患者,保乳手术及放疗后出现IBTR时再次放疗耐受性良好,可能提供长期的局部控制。